A first-of-its-kind effective and innovative tool has been used to treat epilepsy cases at the Royal Medical Services (RMS), it has been announced.
Two advanced epilepsy cases were successfully treated using the Sentiva technology, said RMS Commander Brigadier General Dr Shaikh Fahad bin Khalifa bin Salman Al Khalifa.
The procedures were performed by a team comprising Oral, Maxillofacial and Neck Surgery consultant Dr Mohammed Al Mahraqi, Ear, Nose and Throat Surgery consultant Dr Mohammed Al Shihabi and Paediatric Neurology consultant Dr Raafat Hammad Sarour.
The team conducted comprehensive evaluations and diagnoses of the patients, both of whom were diagnosed with advanced epilepsy that did not respond to medication.
After thorough assessments and considering international protocols and the individual characteristics of the disease, the team developed a tailored treatment plan.
The treatment involved performing surgical procedures to implant electrodes using the Sentiva device, followed by placing the neurostimulator under the skin, typically in the chest area.
Post-surgery, the neurostimulation device was programmed and adjusted to meet the specific needs of each patient.
The procedure took approximately one hour and was successfully completed, enabling the patients to resume their normal lives without experiencing recurrent seizures.
Sentiva is among the most advanced medical technologies, using a sophisticated mechanism to stimulate the vagus nerve to reduce seizure frequency, particularly in patients unresponsive to conventional treatments.
The device allows physicians to adjust stimulation levels to suit individual patient needs, ensuring long-term therapeutic benefits.
Top stories for today:
80 falcons take part in races as part of Mawrooth challenges
Indians in Bahrain mark Republic Day
Emergency hospital urged for special needs children
&uuid=(email))